All the market-moving chatter from Wall Street Monday morning
(This is CNBC Pro’s live coverage of Monday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) Two streaming stocks were in focus early Monday. Morgan Stanley raised its price target on Netflix , calling for more than 16% upside for the stock. Meanwhile, Seaport Research downgraded Roku shares, citing advertising growth headwinds for the company. Check out the latest calls and chatter below. 6:53 a.m. ET: Raymond James upgrades Check Point Software Technologies to outperform Raymond James sees shares of Check Point Software Technologies rising 20% from here. The firm upgraded the cybersecurity stock to outperform from market perform. Its price target of $175 implies 20% upside. The stock has risen more than 15% this year. Analyst Adam Tindle thinks Check Point’s product cycle could refresh in 2024, driving acceleration back to revenue growth. In a previous cycle, a similar dynamic of negative growth in one year led to a “two-year period of acceleration ending in double-digit Billings growth during 2022,” he wrote. “While no two product cycles are necessarily alike, this potential acceleration should occur as key competitors are decelerating, making the notion of Check Point as a ‘share donor’ more difficult to defend and should ultimately aid the valuation multiple,” the analyst added. While Check Point’s subscription revenue has consistently maintained double-digit growth, Tindle believes that 2023 will mark the first year where subscription revenue contributes the largest dollar amount. “This creates a multi-quarter catalyst to the Subscription revenue line throughout 2024 and beyond, and could aid in changing investor perception on CHKP,” he said. — Lisa Kailai Han 6:40 a.m. ET: HSBC initiates Thermo Fisher and Teva as a buy There’s upside ahead for pharmaceutical firms Thermo Fisher and Teva , according to HSBC. The bank initiated coverage of both firms at a buy rating. Thermo Fisher’s target price of $610 implies a nearly 18% upside, while Teva’s target price of $13 means that the stock could rally 30% from here. “We think that Thermo remains one of the best execution stories in the sector,” wrote analyst Sidharth Sahoo. “Coming out of the de-stocking cycle and recovering from the impact of weaker Biotech funding, we think recovery is on the horizon.” Shares of Thermo have fallen nearly 6% this year, but Sahoo said that the company is well-positioned for double-digit earnings growth by adding value to the firms it acquires. TMO YTD mountain TM in 2023 Teva, on the other hand, could see potential upside as the company’s new management works to improve its business model. “A more focused approach in the generics business on higher value opportunities should stabilise revenue and a disciplined plan to pay down debt will lower leverage,” wrote analyst Yifeng Liu. “In addition, the company now has a few promising assets in the innovative medicine business.” Teva stock has risen 9% in 2023. — Lisa Kailai Han 6:10 a.m. ET: JMP downgrades Shopify JMP said that Shopify shares look too expensive after their massive year-to-date rally. Since the start of 2023, the e-commerce platform stock has surged 121%. Analyst Andrew Boone downgraded Shopify to market perform from market outperform, since shares have now neared his prior $80 price target. The stock closed at $76.82 on Friday. “We move to the sidelines and await a more attractive valuation,” he wrote. “With gross merchandise volume growth now more weighted toward enterprise, gross profit margins face new headwinds given lower payment take rates and non-payment Merchant Solution attach rates.” With that in mind, the analyst still believes the company has “tremendous momentum” ahead, citing its share gain with enterprise and offline merchants and dominant position with new merchants as evidence. — Lisa Kailai Han 5:58 a.m. ET: 2024 is the year to own Salesforce stock, Wolfe Research says The rally isn’t over for Salesforce , according to Wolfe Research. The firm upgraded shares of the software company to outperform from peer perform. Analyst Allan Verkhovski’s price target of $315 implies Salesforce can gain an additional 20% on top of this year’s 97% rally. “We think CY24 is the year to own this value growth stock,” the analyst wrote. “Our core thesis is that growth has bottomed and should stay double digits (upside from pricing, product cycles, AI), the commitment to margin leverage is real, leadership is stable while M & A if it happens will be responsible.” The analyst also underscored Salesforce’s position to benefit from the rising prevalence of generative artificial intelligence. — Lisa Kailai Han 5:42 a.m. ET: Seaport Research Partners downgrades Roku Several industry-wide and idiosyncratic headwinds make Roku a tough stock to own, according to Seaport Research Partners. The research firm downgraded the streaming platform name to sell from neutral. Analyst David Joyce’s price target of $75 implies that the stock could fall 22% from its Friday close. Shares of Roku have soared more than 135% this year. As a reason for the downgrade, Joyce cited growth challenges from the broader media spending pullback due to the writers’ and actors’ strikes earlier this year. He thinks it could take a few quarters for the industry to revert back to normal, meaning that content release could still be stunted in 2024. Additional headwinds come from the newly-launched ad tiers of streaming rivals Netflix and Disney+. Joyce wrote that these could worsen over time, especially as Netflix begins introducing its ad tier to a global audience. The analyst also said Roku faces idiosyncratic challenges from lower digital ad growth. “Industry digital ad growth expectations recently marginally improved for 4Q23E and 2024E, but above our estimates for Roku, implying that the company could be losing share,” he said. — Lisa Kailai Han 5:42 a.m. ET: Morgan Stanley raises Netflix price target, downgrades Formula One Morgan Stanley analyst Benjamin Swinburne upped his price target on Netflix to $550 from $475, citing “increasing confidence in the company’s return on content spending, execution on growth initiatives including paid sharing and advertising, and the pull-back in competitive intensity in broader Media.” “We base our growth outlook and investment thesis on three factors: 1) engagement and execution, 2) competition and cost of capital, and 3) a more measured expectation around advertising in particular in nearterm estimates,” Swinburne added. Netflix shares have rallied 60% this year, and Swinburne’s price target calls for upside of 16.5% from Friday’s close. NFLX YTD mountain NFLX in 2023 Separately, Morgan Stanley downgraded Liberty Media Formula One Class C shares to equal weight from overweight. The bank also cut its target on the stock to $70 from $80, implying upside of just 8.7% from Friday’s close. Swinburne called Formula One a “victim of its own success.” The sport’s popularity has exploded in recent years, especially in the U.S., thanks in part to Netflix’s “Drive to Survive” docuseries. “The result of all this success is that earnings have to some extent been optimized,” the analyst said. “While we still see continued strong growth ahead, that growth is going to invariable decelerate from what investors have seen in the past five years.” Class C shares of Formula One are up 11% year to date. Since 2019, they have more than doubled. — Fred Imbert
Aniket Pujari
6,159 PostsAniket Pujari is a passionate finance and technology enthusiast with a strong academic background in Financial Markets. Since 2015, he has been deeply immersed in the world of cryptocurrencies, blockchain technology, and global financial systems, building a wealth of knowledge and expertise in these rapidly evolving fields.
View All Posts